Therapeutic vaccine comprised of engineered hepatitis B surface antigens (HBsAg) that deliver clearance epitope target inserts is being evaluated in the clinic.

CLB-3000-01-001 clinical trial information can be found by clicking the button below.

CLB-4000-1-001 clinical trial information can be found by clicking these buttons below.